6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Pulmonary Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Astakhova, TV; Novoselov, PN; Volchegorskiĭ, IA | 1 |
1 trial(s) available for 6-methyl-2-ethyl-3-hydroxypyridine and Pulmonary Fibrosis
| Article | Year |
|---|---|
[Effect of ascorbic acid and emoxypin on the efficiency of complex chemotherapy for infiltrative pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Ascorbic Acid; Drug Therapy, Combination; Female; Humans; Male; Picolines; Pulmonary Circulation; Pulmonary Fibrosis; Tuberculosis, Pulmonary | 2009 |